Search Results
Dr. Ai on the Use of Hypomethylating Agents in Patients With MDS
Hypomethylating agents for low risk MDS
Using computational algorithms to predict the response of MDS patients to hypomethylating agents
What are hypomethylating agents? #AML
Dr. Ai on the FDA Approval of Mogamulizumab in CTCL
Transplant outcomes of AML/HR-MDS patients treated with sabatolimab plus HMA
Genomics and acute leukemia management: artificial intelligence, deep learning & pre-leukemic clones
What is the role of low-dose hypomethylating agents in myeloid disorders?
Hema Now: Episode 4: Navigating Acute Myeloid Leukemia
Artificial Intelligence in the Workup of Myelodysplastic Syndrome
Can we do better than HMA in HR-MDS?
Autoimmune Disorders and MDS
